Under the response of isoniazid, tgs1 was found to be significantly up-regulated in MDR-Mtb, thus indicating that this gene could represent a significant breakthrough in the monitoring and treatment of drug resistant tuberculosis in the future (Yimcharoen et al., 2022). This evidence concerns the gene TGS1 and tuberculosis.